How to buy N4 Pharma (N4P) shares

Learn how to easily invest in N4 Pharma shares.

N4 Pharma Plc
LSE: N4P - GBX
DRUG MANUFACTURERS-SPECIALTY & GENERIC
p7.55
0.00%

N4 Pharma Plc (N4P) is a leading drug manufacturers-specialty and generic business based in the UK. In the week up to 12 October N4 Pharma shares plunged 8.48% to a closing position of 7.55p. However, over the last 12 months, N4 Pharma's share price has risen by 27.27% from 6.6p. N4 Pharma is listed on the London Stock Exchange (LSE) and employs 5 staff. All prices are listed in pence sterling.

How to buy shares in N4 Pharma

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: N4P in this case.
  5. Research N4 Pharma shares. The platform should provide the latest information available.
  6. Buy your N4 Pharma shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted N4 Pharma's share price?

Since the stock market crash that started in February 2020, N4 Pharma's share price has had significant positive movement.

Its last market close was 7.55p, which is 58.28% up on its pre-crash value of 3.15p and 277.50% up on the lowest point reached during the March 2020 crash when the shares fell as low as 2p.

If you had bought £1,000 worth of N4 Pharma shares at the start of February 2020, those shares would have been worth £901.64 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £2,475.41.

N4 Pharma share price (LSE:N4P)

Use our graph to track the performance of N4P stocks over time.

N4 Pharma shares at a glance

Information last updated 2021-09-17.
Open8.355p
High8.445p
Low8.3p
Close8.4p
Previous close8.4p
Change0p
Change %0%
Volume811,698
Information last updated 2021-10-11.
52-week range5p - 14.5p
50-day moving average8.2554p
200-day moving average8.5136p
Wall St. target price12p
Dividend yieldN/A (0%)
Earnings per share (TTM)-1p
Promoted
eToro Free Stocks

Invest in N4 Pharma shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 1,000x N4 Pharma shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £0.00
£84.00 total
Capital at risk
eToro Free Stocks logo £0 $50 £0.00
£84.00 total
Capital at risk
Fineco logo £0 No minimum £0.00
£84.00 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.76
£85.76 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£95.95 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£91.99 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£93.50 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy N4 Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

N4 Pharma price performance over time

Historical closes compared with the last close of 8.4p

1 week (2021-10-07) 7.01%
1 month (2021-09-17) 8.4
3 months (2021-07-16) -0.59%
6 months (2021-04-16) 4.35%
1 year (2020-10-16) 27.27%
2 years (2019-10-17) 140.69%
3 years (2018-10-17) 68.00%
5 years (2016-10-17) 68.00%

Financials

Revenue TTM £23,524
Gross profit TTM £0
Return on assets TTM -45.82%
Return on equity TTM -68.93%
Profit margin 0%
Book value 0.015p
Market capitalisation £13.9 million

TTM: trailing 12 months

N4 Pharma share dividends

We're not expecting N4 Pharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have N4 Pharma's shares ever split?

N4 Pharma's shares were split on a 200:800 basis on 2 May 2017. So if you had owned 800 shares the day before before the split, the next day you'd have owned 200 shares. This wouldn't directly have changed the overall worth of your N4 Pharma shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for N4 Pharma shares which in turn could have impacted N4 Pharma's share price.

Share price volatility

Over the last 12 months, N4 Pharma's shares have ranged in value from as little as 5p up to 14.5p. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while N4 Pharma's is 0.111. This would suggest that N4 Pharma's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

N4 Pharma in the news

There are no recent company news

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site